ORTEXORTEX News
Tracking PEPB34? Get live short interest, options flow, and signals on ORTEX.Sign up free →
PE
Trader NotePEPB34

PepsiCo BDR Bounces 7% as Q3 Earnings Land

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 20 Oct 2026, 17:31

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

PEPB34, PepsiCo's Brazilian depositary receipt, posted its best weekly gain in months, rising 7.3% to BRL 44.90, as the underlying US stock reacted to Q3 results that landed October 14.

The earnings reaction tells a reasonably constructive short-term story. The October 14 print produced a 4.1% one-day gain in the underlying PEP, a notably stronger response than the prior event in early October, which moved the stock less than 0.1% on the day before recovering 5.3% over the following week. That pattern, modest initial move followed by a multi-day drift higher, has been the dominant shape of PEP's recent earnings behaviour, and the PEPB34 weekly gain reflects the Brazilian market catching up to that move.

The Street's posture remains cautious despite the post-earnings relief. As noted in the October 13 preview, analysts had been cutting targets steadily into the print, with Barclays, Citigroup and JPMorgan all trimming in the days before results. The consensus picture that emerges is one of a Street that has largely de-risked its targets to where the stock already traded, leaving the gap between the consensus mean and current price looking more like residual inertia than genuine bullish conviction. Factor scores add some texture: the dividend rank sits at the 99th percentile, a reminder that income-oriented holders have a structural reason to stay, while EPS momentum scores in the bottom decile on both 30-day and 90-day windows, reflecting the guidance cuts that have weighed on the name all year. The EV/EBIT score of 47 suggests valuation is roughly in line with the sector rather than stretched or cheap.

Borrowing data for PEPB34 specifically is stale, with the last cost-to-borrow reading dating to September 2024, so no current inference on lending market conditions is possible from that source. What can be said is that the ORTEX short score, also last updated in September 2024 at 36.1, is a moderate rather than elevated reading, consistent with the peer note from September which described short positioning as relatively modest. The days-to-cover rank of 77 and utilisation rank of 70 from the factor scores suggest the borrow market is tighter than average for this name without being extreme, and any short positioned against the BDR specifically would be navigating the added complexity of BRL currency moves layered on top of the underlying equity.

Institutional ownership in the underlying PEP is broadly stable. BlackRock added roughly 2.4 million shares in the quarter to September 30, bringing its stake to 8.68% of shares. Charles Schwab Investment Management made the largest proportional addition among top holders, adding 5.6 million shares to reach 2.65%. Those moves are incremental rather than decisive but point to passive and semi-passive flows continuing to absorb supply at current levels.

The next earnings event for PepsiCo is scheduled for January 11, 2027, leaving roughly 12 weeks before the next hard catalyst. Between now and then, the primary watch points are whether the post-Q3 relief rally in PEP has legs against a backdrop of still-deteriorating EPS momentum, and whether the BRL exchange rate amplifies or dampens that move for holders of the PEPB34 receipt.

Stocks in this article

See the live data behind this article on ORTEX.

Open PEPB34 on ORTEX →

How this article was generated

Generated
20 Oct 2026, 17:32
Data as of
20 Oct 2026, 17:31
Prompt version
v1.0
Data sources
EarningsInstitutional positioningRecent ORTEX notesPrevious Mi Articles
Validation notes
  • soft: missing section mentions: short interest (informational only)

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.